IMTX
NASDAQ · Biotechnology
Immatics Nv
$6.18
-0.73 (-10.56%)
Open$6.85
Previous Close$6.91
Day High$7.00
Day Low$6.15
52W High$12.41
52W Low$6.65
Volume—
Avg Volume1.18M
Market Cap1.06B
P/E Ratio—
EPS$-1.59
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+1,150.0% upside
Current
$6.18
$6.18
Target
$77.25
$77.25
$52.47
$77.25 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 57.21M | 87.52M | 330.72M |
| Net Income | -232,860,387 | -320,597,136 | -35,950,365 |
| Profit Margin | -407.0% | -386.7% | -10.9% |
| EBITDA | -204,884,074 | -297,751,063 | -62,958,224 |
| Free Cash Flow | — | — | -53,039,983 |
| Rev Growth | -34.6% | -34.6% | -2.7% |
| Debt/Equity | 0.03 | 0.03 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |